New research shows that three sites spread along an approximately 620-mile portion of today's Denali Fault were once a smaller united geologic feature indicative of the final joining of two land ...
Most recently, Denali Therapeutics initiated dosing in a global BEACON Phase 2a trial of BIIB122 (DNL151) for LRRK2-associated Parkinson’s disease. Denali’s market cap stands at $2.93 billion ...